MedTrace Logo

Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital

NCT04318613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45221

Last updated 2020-06-23

No results posted yet for this study

Summary

The burden of antimicrobial resistance is high in ICUs and antibiotic therapy must continue to be used to improve health and save lives. However, the overuse or inappropriate use of antibiotics across the spectrum of healthcare and in the community is a leading cause of preventable antibiotic resistance development. Several achievements in medicine depend on effective antibiotic therapy and we need to preserve antibiotics to protect future generations. ICU physicians should have regularly updated antibiograms in order to guide appropriate decisions about the choice of empirical antibiotics when waiting for culture results. The appropriate selection of empirical antibiotic therapy should be guided by ICU-specific antibiogram.

Conditions

  • Critical Illness

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Sherif M Mowafy, MD · Anesthesia and Surgical Intensive Care Department, Faculty of Medicine, Zagazig University

  • Essamedin M Negm, MD · Anesthesia and Surgical Intensive Care Department, Faculty of Medicine, Zagazig University

  • Ahmad A Mohammed, MD · Clinical Pathology Department, Faculty of Medicine, Zagazig University

  • Tarek H Hassan, MD · Chest Department, Faculty of Medicine, Zagazig University

  • Marwa G Amer, Master · Clinical Pathology Department, Faculty of Medicine, Zagazig University

  • Ahmed E Tawfik, Bachelor · Clinical pharmacist, Zagazig University Hospitals

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04318613 on ClinicalTrials.gov